S-Nitrosoglutathione induces functional ΔF508-CFTR in airway epithelial cells

Biochemical and Biophysical Research Communications

Volumn 297, Issue 3, 2002, Pages 552-557

  Andersson, Charlotte ^a   Gaston, Benjamin ^b   Roomans, Godfried M ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

CFTR; Chloride transport; Cystic fibrosis; Immunocytochemistry; MQAE; S Nitrosoglutathione

Indexed keywords

CHLORIDE; CYCLIC AMP; FLUORESCENT DYE; QUINOLONE DERIVATIVE; S NITROSOGLUTATHIONE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL MEMBRANE; CHLORIDE TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG MECHANISM; EPITHELIUM CELL; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; CHLORIDES; CYCLIC AMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FLUORESCENT DYES; FORSKOLIN; MUTAGENESIS; NIGERICIN; NITRIC OXIDE DONORS; RECOMBINANT PROTEINS; RESPIRATORY MUCOSA; S-NITROSOGLUTATHIONE; SEQUENCE DELETION;

EID: 0036392160     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02245-3     Document Type: Article

References (48)

1. J.R. Riordan, J.M. Rommens, B. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, J. Zielenski, S. Lok, N. Plavsic, J.L. Chou, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science 245 (1989) 1066-1073.
2. G.L. Lukacs, A. Mohamed, N. Kartner, X.B. Chang, J.R. Riordan, S. Grinstein, Conformational maturation of CFTR but not its mutant counterpart (ΔF508) occurs in the endoplasmic reticulum and requires ATP, EMBO J. 13 (1994) 6076-6086.
3. C.L. Ward, R.R. Kopito, Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins, J. Biol. Chem. 269 (1994) 25710-25718.
4. S. Sato, C.L. Ward, R.R. Kopito, Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro, J. Biol. Chem. 273 (1998) 7189-7192.
5. X. Xiong, E. Chong, W.R. Skach, Evidence that endoplasmic reticulum (ER)-associated degradation of cystic fibrosis trans-membrane conductance regulator is linked to retrograde translocation from the ER membrane, J. Biol. Chem. 274 (1999) 2616-2624.
6. G.C. Meacham, Z. Lu, S. King, E. Sorscher, A. Tousson, D.M. Cyr, The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis, EMBO J. 18 (1999) 1492-1505.
7. S. Pind, J.R. Riordan, D.B. Williams, Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator, J. Biol. Chem. 269 (1994) 12784-12788.
8. Y. Yang, S. Janich, J.A. Cohn, J.M. Wilson, The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment, Proc. Natl. Acad. Sci. USA 90 (1993) 9480-9484.
9. S.H. Cheng, R.J. Gregory, J. Marshall, S. Paul, D.W. Souza, G.A. White, C.R. O'Riordan, A.E. Smith, Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis, Cell 63 (1990) 827-834.
10. G.M. Denning, M.P. Anderson, J.F. Amara, J. Marshall, A.E. Smith, M.J. Welsh, Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive, Nature 358 (1992) 761-764.
11. W. Dalemans, P. Barbry, G. Champigny, S. Jallat, K. Dott, D. Dreyer, R.G. Crystal, A. Pavirani, J.P. Lecocq, M. Lazdunski, Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation, Nature 354 (1991) 526-528.
12. C.R. Brown, L.Q. Hong-Brown, J. Biwersi, A.S. Verkman, W.J. Welch, Chemical chaperones correct the mutant phenotype of the ΔF508 cystic fibrosis transmembrane conductance regulator protein, Cell Stress Chaperones 1 (1996) 117-125.
13. R.C. Rubenstein, M.E. Egan, P.L. Zeitlin, In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing ΔF508-CFTR, J. Clin. Invest. 100 (1997) 2457-2465.
14. R. Maitra, C.M. Shaw, B.A. Stanton, J.W. Hamilton, Functional enhancement of CFTR expression by mitomycin C, Cell. Physiol. Biochem. 11 (2001) 93-98.
15. R. Maitra, C.M. Shaw, B.A. Stanton, J.W. Hamilton, Increased functional cell surface expression of CFTR and ΔF508-CFTR by the anthracycline doxorubicin, Am. J. Physiol. Cell. Physiol. 280 (2001) C1031-C1037.
16. H. Fischer, N. Fukuda, P. Barbry, B. Illek, C. Sartori, M.A. Matthay, Partial restoration of defective chloride conductance in ΔF508 CF mice by trimethylamine oxide, Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L52-L57.
17. M. Srivastava, O. Eidelman, H.B. Pollard, Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis, Mol. Med. 5 (1999) 753-767.
18. K. Zaman, M. McPherson, J. Vaughan, J. Hunt, F. Mendes, B. Gaston, L.A. Palmer, S-Nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation, Biochem. Biophys. Res. Commun. 284 (2001) 65-70.
19. H. Grasemann, B. Gaston, K. Fang, K. Paul, F. Ratjen, Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function, J. Pediatr. 135 (1999) 770-772.
20. B. Gaston, J.M. Drazen, A. Jansen, D.A. Sugarbaker, J. Loscalzo, W. Richards, J.S. Stamler, Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro, J. Pharmacol. Exp. Ther. 268 (1994) 978-984.
21. D. Li, G. Shirakami, X. Zhan, R.A. Johns, Regulation of ciliary beat frequency by the nitric oxide-cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells, Am. J. Respir. Cell. Mol. Biol. 23 (2000) 175-181.
22. L. Jain, X.J. Chen, L.A. Brown, D.C. Eaton, Nitric oxide inhibits lung sodium transport through a cGMP-mediated inhibition of epithelial cation channels, Am. J. Physiol. 274 (1998) L475-L484.
23. B. Kamosinska, M.W. Radomski, M. Duszyk, A. Radomski, S.F. Man, Nitric oxide activates chloride currents in human lung epithelial cells, Am. J. Physiol. 272 (1997) L1098-L1104.
24. J.D. Fortenberry, M.L. Owens, L.A. Brown, S-Nitrosoglutathione enhances neutrophil DNA fragmentation and cell death, Am. J. Physiol. 276 (1999) L435-L442.
25. T. Persichini, M. Colasanti, G.M. Lauro, P. Ascenzi, Cysteine nitrosylation inactivates the HIV-1 protease, Biochem. Biophys. Res. Commun. 250 (1998) 575-576.
26. A.S. Verkman, Development and biological applications of chloride-sensitive fluorescent indicators, Am. J. Physiol. 259 (1990) C375-C388.
27. A.C. Chao, J.H. Widdicombe, A.S. Verkman, Chloride conductive and cotransport mechanisms in cultures of canine tracheal epithelial cells measured by an entrapped fluorescent indicator, J. Membr. Biol. 113 (1990) 193-202.
28. 2+ signalling in glucose-stimulated pancreatic β-cells, Cell. Signal. 12 (2000) 781-786.
29. D. Penque, F. Mendes, S. Beck, C. Farinha, P. Pacheco, P. Nogueira, J. Lavinha, R. Malho, M.D. Amaral, Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells, Lab. Invest. 80 (2000) 857-868.
30. R.W. Lehrich, S.G. Aller, P. Webster, C.R. Marino, J.N. Forrest Jr., Vasoactive intestinal peptide, forskolin, and genistein increase apical CFTR trafficking in the rectal gland of the spiny dogfish, Squalus acanthias. Acute regulation of CFTR trafficking in an intact epithelium, J. Clin. Invest. 101 (1998) 737-745.
31. M. Srivastava, O. Eidelman, H.B. Pollard, Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis, Mol. Med. 5 (1999) 753-767.
32. B.E. Cohen, G. Lee, K.A. Jacobson, Y.C. Kim, Z. Huang, E.J. Sorscher, H.B. Pollard, 8-Cyclopentyl-1,3-dand and other xanthines differentially bind to the wild-type and ΔF508 first nucleotide binding fold (NBF-1) domains of the fibrosis transmembrane conductance regulator, Biochemistry 36 (1997) 6455-6461.
33. T.C. Hwang, F. Wang, I.C. Yang, W.W. Reenstra, Genistein potentiates wild-type and ΔF508-CFTR channel activity, Am. J. Physiol. 273 (1997) C988-C998.
34. F. Wang, S. Zeltwanger, I.C. Yang, A.C. Nairn, T.C. Hwang, Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effects, J. Gen. Physiol. 111 (1998) 477-490.
35. F. Weinreich, P.G. Wood, J.R. Riordan, G. Nagel, Direct action of genistein on CFTR, Pflugers Arch. 434 (1997) 484-491.
36. C.M. Farinha, P. Nogueira, F. Mendes, D. Penque, M.D. Amaral, The Hdj-1/Hsp40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70, Biochem. J. (2002) [epub ahead of print].
37. L.R. Choo-Kang, P.L. Zeitlin, Induction of HSP70 promotes ΔF508-CFTR trafficking, Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L58-L68.
38. R.C. Rubenstein, P.L. Zeitlin, Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of ΔF508-CFTR, Am. J. Physiol. Cell. Physiol. 278 (2000) C259-C267.
39. R.C. Rubenstein, B.M. Lyons, Sodium 4-phenylbutyrate downregulates HSC70 expression by facilitating mRNA degradation, Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L43-L51.
40. J.H. Roum, R. Buhl, N.G. McElvaney, Z. Borok, R.G. Crystal, Systemic deficiency of glutathione in cystic fibrosis, J. Appl. Physiol. 75 (1993) 2419-2424.
41. L. Gao, K.J. Kim, J.R. Yankaskas, H.J. Forman, Abnormal glutathione transport in cystic fibrosis airway epithelia, Am. J. Physiol. 277 (1999) L113-L118.
42. L. Gao, J.R. Broughman, T. Iwamoto, J.M. Tomich, C.J. Venglarik, H.J. Forman, Synthetic chloride channel restores glutathione secretion in cystic fibrosis airway epithelia, Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L24-L30.
43. T.J. Kelley, M.L. Drumm, Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells, J. Clin. Invest. 102 (1998) 1200-1207.
44. K. Fang, R. Johns, T. Macdonald, M. Kinter, B. Gaston, S-Nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig, Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000) L716-L721.
45. V.M. Hudson, Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation, Free Radic. Biol. Med. 30 (2001) 1440-1461.
46. B. Gaston, S. Sears, J. Woods, J. Hunt, M. Ponaman, T. McMahon, J.S. Stamler, Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure, Lancet 351 (1998) 1317-1319.
47. Q.H. Meng, D.R. Springall, A.E. Bishop, K. Morgan, T.J. Evans, S. Habib, D.C. Gruenert, K.M. Gyi, M.E. Hodson, M.H. Yacoub, J.M. Polak, Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis, J. Pathol. 184 (1998) 323-331.
48. A.H. Snyder, M.E. McPherson, J.F. Hunt, M. Johnson, J.S. Stamler, B. Gaston, Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis, Am. J. Respir. Crit. Care Med. 165 (2002) 922-926.